تنبيه سريري تجريبي

إخلاء مسؤولية: هذه المنصات هي عمل شخصي للدكتور علي الإبراهيم، وهي في المرحلة التجريبية (بيتا) وقد تحتوي على أخطاء. يرجى الإبلاغ عن أي أخطاء أو مقترحات للتحسين إلى Alioud16@gmail.com

الغرض من الأداة ومصادرها وحدودها

منصة دعم القرار السريري لاستسقاء الجنين (Fetal Hydrops)، تأكيد التشخيص، تصنيف المناعي وغير المناعي، وعمل الفحوصات والخطط العلاجية.

منصة مهنية في مرحلة بيتا. راجع المصادر ونطاق النموذج والوحدات قبل تفسير النتائج. لا يعني التحقق البرمجي اعتماداً سريرياً.

طرق الاستخدام ومعايير الأدلة ↗
FETAL MEDICINE · FLUID FINDINGS & MATERNAL SAFETY

Fetal Hydrops Workbench

Recognize the pattern. Investigate in parallel.
Keep maternal safety at the centre.

SMFM 2026 · Local review v2Clinical approval pending
CLINICAL ENTRY

Findings first. Safety always.

Tab moves forward; Shift+Tab returns. Enter advances text / number fields. Native select and Space keys are preserved. Ctrl / ⌘ + Enter reviews.

1 · Case & fluid compartments0 recorded

Document each compartment separately. Bilateral pleural fluid counts once. Unknown never means absent.

A small physiological rim must not be counted. >2–3 mm requires expert interpretation; no hidden 2.5-mm switch.
Generalized skin thickness >5 mm supports the conventional criterion. A focal thickening is not a systemic compartment.
2 · Maternal safety & immune review0 recorded

Maternal danger signs require assessment even if fetal measurements are missing. Mirror syndrome is a clinical diagnosis, not a calculated score.

3 · MCA / anemia assessment0 recorded

MCA is an anemia screen, not a measured hemoglobin or an IUT order. Uses the same median function as the reviewed transfusion workbench.

4 · Phenotype & family context0 recorded

These findings select relevant review pathways. They do not produce ranked probabilities or an etiologic diagnosis.

5 · Diagnostic testing tracker0 recorded

Investigations proceed in parallel, guided by the phenotype, urgency and patient preferences. Mark reviewed only when the result has been assessed.

6 · MDT, birth & follow-up0 recorded

Timing, fetal therapy and goals of care require individualized specialist decisions. No default delivery date, treatment or prognosis is generated.

CONFIRM THE PATTERN · FIND THE CAUSE · PROTECT THE MOTHER

No case entered

Start with a blank case. No fluid absence, normal BP, negative antibody screen or care preference is assumed.

DOCUMENTED COMPARTMENTS0 / 44 unassessed / equivocal
MCA SCREEN—Check quality, GA and IUT history
WORKUP TASKS—Outstanding applicable tasks; not a completeness score

Hydrops is a syndrome, not a final diagnosis

Confirm the abnormal spaces and review anatomy, cardiac rhythm, anemia, infection, genetics and placental / twin causes in parallel. One effusion can warrant a similar diagnostic assessment, but its cause and prognosis may differ. Localized fluid from a urinary or bowel process needs its own evaluation.

SMFM Consult #75 · Non-immune hydrops / effusion spectrum (2026) ↗

Go to clinical entry

New case entries stay in this page’s memory; no case storage or transmission is introduced. Reload / reset clears the current in-memory case. Saved cases from previous versions are not loaded. Copied, exported and printed records remain under your control.

Clear this input section?

Fields in this section return to blank / unknown. Other sections remain; verify the retained context and planning details. The handover acknowledgement will be cleared.

Four fluid compartments

Educational conceptual medical cutaways distinguish blue pleural fluid around lungs, pericardial fluid outside the heart, free peritoneal ascites around abdominal organs and fluid expanding subcutaneous tissue. Bilateral pleural effusions count as one compartment.

Pathological fluid must be confirmed in the correct anatomical space. Generalized edema requires assessment of distribution; this local tissue cutaway cannot establish generalized disease. Placental thickening and polyhydramnios are not additional fetal compartments.

Educational illustrations · Educational only · Not to scale · Clinical approval pending.

معلومات المنصة والمراجع

Version: 2.0 local review
Guideline version: SMFM Consult #75 (2026); SMFM anemia #8; BSH antibodies 2025
Last reviewed date: 20 October 2026
Formula source: Shared transfusion-workbench MCA median, exp(2.31 + 0.0464 × exact GA)
Coefficient source: 18+0–40+0 calculation window; routine screening gates limited to <35 weeks and no prior IUT
Validation notes: Local automated and browser checks; clinical validation / illustration approval required
Known limitations: No etiology probability, survival forecast, severity / mirror score, treatment eligibility or automatic delivery timing. Unknown is not normal. Prior-version saved cases are not loaded.
What changed in this version: 2026 evidence update; explicit compartment / immune uncertainty; parallel workup tracker; independent maternal alerts; shared MCA curve; keyboard workflow; consistent reset; current-case reports; educational atlas.
© 2026 Dr. Ali Hussein Al Ibrahim. All rights reserved.